Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

1,029

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

October 31, 2005

Conditions
Erectile Dysfunction
Interventions
BEHAVIORAL

Levitra (Vardenafil, BAY38-9456)

The Primary Care Physician (PCP) received the educational intervention

BEHAVIORAL

Levitra (Vardenafil, BAY38-9456)

The Subject received the educational intervention

BEHAVIORAL

Levitra (Vardenafil, BAY38-9456)

Both the Primary Care Physician (PCP) and the subject received the educational intervention

OTHER

No Education

No education provided to either the Primary Care Physician (PCP) or the subject.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY